239 related articles for article (PubMed ID: 27956455)
21. Risk factors for ocular chlamydia after three mass azithromycin distributions.
Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
[TBL] [Abstract][Full Text] [Related]
22. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
[TBL] [Abstract][Full Text] [Related]
23. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
[TBL] [Abstract][Full Text] [Related]
24. Targeted Antibiotics for Trachoma: A Cluster-Randomized Trial.
Melo JS; Aragie S; Chernet A; Tadesse Z; Dagnew A; Hailu D; Haile M; Zeru T; Wittberg DM; Nash SD; Callahan EK; Arnold BF; Porco TC; Lietman TM; Keenan JD
Clin Infect Dis; 2021 Sep; 73(6):979-986. PubMed ID: 33674869
[TBL] [Abstract][Full Text] [Related]
25. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
[TBL] [Abstract][Full Text] [Related]
26. Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger.
Oldenburg CE; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Gaynor BD
Pediatr Infect Dis J; 2018 Jun; 37(6):506-510. PubMed ID: 29088030
[TBL] [Abstract][Full Text] [Related]
27. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
Atik B; Thanh TT; Luong VQ; Lagree S; Dean D
JAMA; 2006 Sep; 296(12):1488-97. PubMed ID: 17003397
[TBL] [Abstract][Full Text] [Related]
28. Stopping azithromycin mass drug administration for trachoma: A systematic review.
Mahmud H; Landskroner E; Amza A; Aragie S; Godwin WW; de Hostos Barth A; O'Brien KS; Lietman TM; Oldenburg CE
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009491. PubMed ID: 34237074
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.
Liu F; Porco TC; Mkocha HA; Muñoz B; Ray KJ; Bailey RL; Lietman TM; West SK
Epidemics; 2014 Mar; 6():10-7. PubMed ID: 24593917
[TBL] [Abstract][Full Text] [Related]
30. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
Marks M; Bottomley C; Tome H; Pitakaka R; Butcher R; Sokana O; Kako H; Solomon AW; Mabey DC
Sex Transm Infect; 2016 Jun; 92(4):261-5. PubMed ID: 26888658
[TBL] [Abstract][Full Text] [Related]
31. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
[TBL] [Abstract][Full Text] [Related]
32. Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial.
Oldenburg CE; Amza A; Cooley G; Kadri B; Nassirou B; Arnold BF; Rosenthal PJ; O'Brien KS; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Martin DL
Malar J; 2019 Dec; 18(1):389. PubMed ID: 31796025
[TBL] [Abstract][Full Text] [Related]
33. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
Lee JS; Muñoz BE; Mkocha H; Gaydos CA; Quinn TC; West SK
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2761. PubMed ID: 24722392
[TBL] [Abstract][Full Text] [Related]
34. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.
Keenan JD; Lakew T; Alemayehu W; Melese M; Porco TC; Yi E; House JI; Zhou Z; Ray KJ; Acharya NR; Whitcher JP; Gaynor BD; Lietman TM
Am J Trop Med Hyg; 2010 Mar; 82(3):482-7. PubMed ID: 20207878
[TBL] [Abstract][Full Text] [Related]
35. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
[TBL] [Abstract][Full Text] [Related]
36. A rationale for continuing mass antibiotic distributions for trachoma.
Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
[TBL] [Abstract][Full Text] [Related]
38. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
Harding-Esch EM; Sillah A; Edwards T; Burr SE; Hart JD; Joof H; Laye M; Makalo P; Manjang A; Molina S; Sarr-Sissoho I; Quinn TC; Lietman T; Holland MJ; Mabey D; West SK; Bailey R;
PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
[TBL] [Abstract][Full Text] [Related]
39. Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
House JI; Ayele B; Porco TC; Zhou Z; Hong KC; Gebre T; Ray KJ; Keenan JD; Stoller NE; Whitcher JP; Gaynor BD; Emerson PM; Lietman TM
Lancet; 2009 Mar; 373(9669):1111-8. PubMed ID: 19329003
[TBL] [Abstract][Full Text] [Related]
40. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
